Use of Methylphenidate for Attention-Deficit Hyperactivity Disorder in Patients With Epilepsy or Electroencephalographic Abnormalities

Abstract

Methylphenidate is commonly believed to lower seizure threshold. The safe use of methylphenidate has not been clarified in patients with attention-deficit hyperactivity disorder (ADHD) and concomitant active seizure or electroencephalographic (EEG) abnormalities. Patients with ADHD and active seizures (n = 57) and patients with ADHD and EEG abnormalities (n = 62), 6 to 16 years of age, were included in the study. The safety and efficacy of treatment with antiepilepsy drugs combined with methylphenidate were determined by assessing seizure frequency, changes in ADHD symptoms, the Conners' Rating Scales, EEG differences, and side effects. The Conners' Rating Scales, performed by parents and teachers, and mean total ADHD symptom scores at the beginning of the study and at the end were significantly different (P = .05 for the Conners' Rating Scales and P = .001 for ADHD symptom scores). Methylphenidate had a beneficial effect on EEG. Seizure frequency did not change from baseline. The side effects of methylphenidate were mild and transient. Methylphenidate is safe and effective in children with ADHD and concomitant active seizures or EEG abnormalities. (J Child Neurol 2003;18:109—112).

Get full access to this article

View all access options for this article.

References

Cantwell DP : Attention deficit disorder: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996;35:978—987.

MTA Cooperative Group : A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073—1086.

Miller KJ , Castellanos FX : Attention deficit/hyperactivity disorders. Pediatr Rev 1998;19:373—384.

American Psychiatric Association : Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, APA Press, 1994.

Barkley RA : Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment . New York, Guilford, 1990, 573—612.

Kinsbourne M. , Graf WD : Disorders of mental development, in Menkes JH , Sarnat HB (eds): Child Neurology, 6th ed. Philadelphia , Lippincott Williams and Wilkins, 2000, 1155—1211.

Shaywits BA , Flietcher JM , Shaywits SE : Attention deficit hyperactivity disorder, in Swaiman KF , Ashwall S (eds): Pediatric Neurology Principles and Practice, 3rd ed. St Louis, Mosby, 1999, 585—597.

Stein MA , Blondis TA , Schnitzler ER , et al: Methylphenidate dosing:Twicedailyversusthreetimesdaily. Pediatrics 1996;98:748—756.

Feldman H. , Crumrine P. , Handen BL , et al: Methylphenidate in children with seizures and attention deficit disorder. Am J Dis Child 1989;143:1081—1086.

10.

McBride M. , West Torres C : Methylphenidate in therapeutic doses does not lower threshold. Ann Neurol 1986; 20:428.

11.

Semrud-Clikeman M. , Wical B. : Components of attention in children with complex partial seizures with and without ADHD. Epilepsia 1999,40:211—215.

12.

Gross-Tsur V. , Manor O. , van der Meere J. , et al: Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective? J Pediatr 1997; 130:40—44.

13.

Hemmer SA , Pasternak JF , Zecker SG , Trommer BL : Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol 2001;24:99—102.

14.

Finck S. , Metz-Lutz M-N. , Becache E. , et al: Attention-deficit hyperactivity disorder in epileptic children: A new indication for methylphenidate? Ann Neurol 1995; 38:520.

15.

Goyette CH , Conners CK , Ulrich RF : Normative data on revised Conners' Parent and Teacher Rating Scales. J Abnorm Child Psychol 1978; 6: 221—236.

16.

American Academy of Pediatrics, Committee on Drugs : Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics 1995;96:538—540.

17.

Ross EM , Peckham CS , West PB : Epilepsy in childhood: Findings from the National Child Development Study . BMJ 1980; 1: 207—210.

18.

Sillanpaa M. : Epilepsy in children: Prevalence, disability and handicap. Epilepsia 1992;33:444—449.

19.

Bennet-Levy J. , Stores G. : The nature of cognitive dysfunction in school children with epilepsy. Acta Neurol Scand Suppl 1984;99:79—82.

20.

Lindsay J. , Ounsted C. , Richards P. : Long-term outcome in children with temporal lobe epilepsy. Dev Med Child Neurol 1984; 26: 25—32.

21.

Powell AL , Yudd A. , Zee P. , Mandelbaum DE : Attention deficit hyperactivity disorder associated with orbitofrontal epilepsy in a father and a son. Neuropsychiatry Neuropsychol Behav Neurol 1997; 10: 151—154

22.

Williams J. , Sharp G. , Lange B. , et al: The effects of seizure type, level of seizure control, and antiepileptic drugs on memory and attention skillsinchildrenwithepilepsy . Dev Neuropsychol 1996;12:241—253.

23.

Safer D. , Zito JM , Fine EM : Increased methylphenidate usage for attentiondeficitdisorderinthe1990's. Pediatrics 1996;98:1084—1088.

24.

Efron D. , Jarman F. , Barker M. : Side effects of methylphenidate and dexamphetamine in children with attention-deficit/hyperactivity disorder:Adouble-blindcross-overtrial. Pediatrics 1997;100:662—666.

25.

Klein RG , Wender P. : The role of methylphenidate in psychiatry. Arch Gen Psychiatry . 1995;52:429—433.

26.

Physicians' Desk Reference. Oradell, NJ, Medical Economics, 1988.

27.

Wroblewski BA , Leary JM , Phelan AM , et al: Methylphenidate and seizure frequency in brain-injured patients with seizure disorders. J Clin Psychiatry 1992;53:86—89.